NYKODE THERAPEUTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.24 NOK | +2.00% |
|
+0.61% | -38.13% |
Chart calendar Nykode Therapeutics
b4986be254cc.S7-v-0gNf9nroyfLfBWPnf6wXwEz4a8bBE8vie9bU-c.Ds3hsiY7NZ-IyGuZFm3IpJjHFjBktd1RTQhjzr83ONN79cuofksntZ_6fg~fb3d463d9365436bacd0d63cf05f4b32
Upcoming events on Nykode Therapeutics
Past events on Nykode Therapeutics
| 2024-02-28 10:00 am | Q4 2023 Earnings Call |
| 2024-02-28 01:00 am | Q4 2023 Earnings Release |
| 2024-01-10 06:45 pm | J.P. Morgan Healthcare Conference |
| 2023-11-15 10:00 am | Q3 2023 Earnings Call |
| 2023-11-15 04:30 am | Q3 2023 Earnings Release |
| 2023-10-12 10:00 am | MRNA Cancer Vaccines Summit |
| 2023-09-11 | H.C. Wainwright Global Investment Conference |
| 2023-08-23 09:00 am | Q2 2023 Earnings Call |
| 2023-08-23 12:45 am | Q2 2023 Earnings Release |
| 2023-06-07 10:00 am | Jefferies Global Healthcare Conference |
| 2023-05-30 12:00 am | ABGSC Life Science Summit |
| 2023-05-12 04:01 am | Q1 2023 Earnings Call |
| 2023-05-12 01:00 am | Q1 2023 Earnings Release |
| 2023-05-11 04:00 am | Annual General Meeting |
| 2023-04-19 10:00 am | VB-C-02 Phase 2 Trail Results Call |
| 2023-02-28 10:00 am | Q4 2022 Earnings Call |
| 2023-02-28 01:00 am | Q4 2022 Earnings Release |
| 2023-02-16 08:00 am | SVB Securities Global Biopharma Conference |
| 2023-01-09 04:30 pm | JP Morgan Healthcare Conference |
| 2022-12-20 10:00 am | Business Update Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million NOK | Released Forecast Spread | 12,4 12,0 3.72% | 0,00 | 314 366 -14.34% | 93,3 55,6 67.79% | 141 122 15.74% | 157 |
|
EBITDA Million NOK | Released Forecast Spread | -98,8 -85,0 -16.18% | 0,00 | -87,9 10,6 -929.18% | -543 -505 -7.36% | -593 -621 4.51% | -667 |
|
EBIT Million NOK | Released Forecast Spread | -98,9 -85,0 -16.34% | 0,00 | -94,4 10,6 -990.13% | -549 -564 2.62% | -615 -650 5.32% | -692 |
|
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | -96,0 -83,0 -15.61% | 0,00 | -97,4 4,79 -2131.68% | -527 -543 3% | -467 -590 20.89% | -636 |
|
Net income Million NOK | Released Forecast Spread | 0,00 0,00 - | 1 249 | -82,3 4,79 -1817.89% | -442 -447 1.23% | -372 -521 28.59% | -613 |
|
EPS NOK | Released Forecast Spread | -0,35 -0,31 -13.34% | 4,25 | -0,26 0,01 -5354.6% | -1,55 -1,55 -0.33% | -1,27 -1,74 27.16% | -1,86 |
| Announcement Date | 15/04/20 | 21/04/21 | 31/03/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million NOK | Released Forecast Spread | 278 272 2.31% | 33,2 53,3 -37.71% | 13,0 105 -87.64% | 34,1 10,2 235.85% | 33,3 13,0 156.81% | 54,2 12,6 328.9% | 30,3 | 24,1 22,9 5.51% | 66,9 | 66,9 | 66,9 | 66,9 |
|
EBITDA Million NOK | Released Forecast Spread | 132 168 -21.05% | -94,9 -57,0 -66.49% | -197 -6,75 -2827.29% | -121 -164 25.92% | -148 -175 15.13% | -176 -167 -4.85% | -157 | -161 | -166 | -170 | ||
|
EBIT Million NOK | Released Forecast Spread | 129 168 -23.27% | -99,4 -57,0 -74.31% | -202 -6,75 -2895.79% | -149 -141 -5.73% | -127 -169 24.74% | -154 -179 13.87% | -182 -173 -5.05% | -164 | -168 | -172 | -176 | |
|
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | 134 168 -20.25% | -106 -57,0 -85.83% | -195 -6,75 -2789.08% | -127 -133 4.62% | -109 -161 32.5% | -134 -187 28.3% | -100 -172 41.85% | -170 | -174 | -178 | -183 | |
|
Net income Million NOK | Released Forecast Spread | 94,3 168 -43.81% | -84,9 -57,0 -48.84% | -151 -6,75 -2140.86% | -126 -120 -5.11% | -97,9 -145 32.42% | -110 -187 40.83% | -56,5 -164 65.47% | -170 | -174 | -178 | -183 | |
|
EPS NOK | Released Forecast Spread | -0,41 -0,41 0.16% | -0,32 -0,50 36.23% | -0,32 -0,64 49.77% | -0,21 -0,53 59.85% | -0,53 | -0,53 | -0,53 | -0,53 | ||||
| Announcement Date | 31/03/22 | 23/08/22 | 23/11/22 | 28/02/23 | 12/05/23 | 22/08/23 | 15/11/23 | 28/02/24 | - | - | - | - |
| Today 04:05 pm | EXELIXIS, INC.: Q1 2024 Earnings Release |
| 2024-04-30 | SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release |
| 2024-04-30 | MACROGENICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | REGENXBIO INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 07:00 am | NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-01 04:05 pm | SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | GERON CORPORATION: Q1 2024 Earnings Release |
Past sector events for Nykode Therapeutics
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VACC Stock
- Calendar Nykode Therapeutics
